0
0
Home » Medical Devices » Nephrology and Urology Devices

Urinary Tract Stents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

The urinary tract stents market was valued at $329.6 million in the year 2021. The urinary tract stents market analysis and forecast model is built to visualize quantitative market trends within nephrology and urology devices therapeutic area. The model discusses in detail the impact of COVID-19 on urinary tract stents market for the year 2020 and beyond.

Urinary tract stents market overview

Urinary tract stents market overview

 

For more insights on this report, download a free sample

What are the market dynamics in the urinary tract stents sector?

Urinary tract stents are the tubular devices made either of polymers and metal which are inserted into the urinary tract or ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder. A ureteral stent is specially designed a soft tube 10-12 inches in length that is placed in the ureter for draining urine from the kidney to the urinary bladder. The increasing prevalence of prostate cancer, benign prostatic hyperplasia (BPH), urolithiasis and stone among people in the kidney has seen a staggering rise over the years. This is anticipated to propel the demand for urinary tract stenting over the forecast periods. The developing number of individuals facing difficulties in passing urine normally is one of the key reasons why the demand for urinary tract stenting is increasing throughout the years.

Which are the key regions in the urinary tract stents market?

The key regions in the urinary tract stents market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

Urinary tract stents market, by key regions

Urinary tract stents market, by key regions

For more regional insights, download a free sample

What are the key segments in the urinary tract stents market?

The key segments in the urinary tract stents market are prostate stents, ureteral stents, and urethral stents. Ureteral stents has the highest market value in the urinary tract stents market.

Urinary tract stents market, by segments

Urinary tract stents market, by segments

For more segment insights, download a free sample

Which are the key companies in the urinary tract stents market?

The key companies in the urinary tract stents market are Boston Scientific Corp, Cook Group Inc, Becton Dickinson and Co, Olympus Corp, Coloplast A/S, Applied Medical Corporation, Allium Medical Solutions Ltd, Pnn Medical A/S, and SRS Medical Systems Inc.

Urinary tract stents market, by key companies

Urinary tract stents market, by key companies

To know more about key companies, download a free sample

Market report scope

Market size 2021 $329.6 million
Forecast period 2021-2030
Key regions North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa
Key segments Prostate Stents, Ureteral Stents, and Urethral Stents
Key companies Avanos Medical Inc, Otsuka Holdings Co Ltd, Meridian Bioscience Inc, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Siemens AG, Trinity Biotech Plc, Merck KGaA, and Sekisui Chemical Ltd

Scope

This market model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the urinary tract stents marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on urinary tract stents market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving urinary tract stents market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the urinary tract stents market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific urinary tract stents market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

Boston Scientific Corp

Cook Group Inc

Becton Dickinson and Co

Olympus Corp

Coloplast A/S

Applied Medical Corporation

Allium Medical Solutions Ltd

Pnn Medical A/S

SRS Medical Systems Inc

Others

Frequently Asked Questions

The urinary tract stents market size was $329.6 million in the year 2021.

North America, South & Central America, Europe, Asia-Pacific, and Middle East & Africa are the key regions in the urinary tract stents market.

Prostate stents, ureteral stents, and urethral stents are the key segments in the urinary tract stents market.

Boston Scientific Corp, Cook Group Inc, Becton Dickinson and Co, Olympus Corp, Coloplast A/S, Applied Medical Corporation, Allium Medical Solutions Ltd, Pnn Medical A/S, and SRS Medical Systems Inc are the key companies in the urinary tract stents market.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports